DE2006750A1 - Verfahren zur Herstellung von Benzodiazepinen - Google Patents
Verfahren zur Herstellung von BenzodiazepinenInfo
- Publication number
- DE2006750A1 DE2006750A1 DE19702006750 DE2006750A DE2006750A1 DE 2006750 A1 DE2006750 A1 DE 2006750A1 DE 19702006750 DE19702006750 DE 19702006750 DE 2006750 A DE2006750 A DE 2006750A DE 2006750 A1 DE2006750 A1 DE 2006750A1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- benzodiazepines
- preparation
- formula
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 229940049706 benzodiazepine Drugs 0.000 title claims description 5
- 150000001557 benzodiazepines Chemical class 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 2
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical group 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 230000035943 smell Effects 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 1
- 229960004535 oxazepam Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT260069 | 1969-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2006750A1 true DE2006750A1 (de) | 1970-10-01 |
Family
ID=3537189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702006750 Pending DE2006750A1 (de) | 1969-03-17 | 1970-02-14 | Verfahren zur Herstellung von Benzodiazepinen |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH527829A (enExample) |
| DE (1) | DE2006750A1 (enExample) |
| GB (1) | GB1252856A (enExample) |
-
1970
- 1970-02-14 DE DE19702006750 patent/DE2006750A1/de active Pending
- 1970-02-19 CH CH237470A patent/CH527829A/de not_active IP Right Cessation
- 1970-02-23 GB GB1252856D patent/GB1252856A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1252856A (enExample) | 1971-11-10 |
| CH527829A (de) | 1972-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2030402C3 (enExample) | ||
| CH618686A5 (enExample) | ||
| DE2916889C2 (de) | Verfahren und Zwischenprodukte zur Herstellung von 6α-Halogen-3-Keto-Δ↑1↑↑,↑↑4↑-pregnadienderivaten | |
| DE2318767C3 (de) | Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
| DE1962757B2 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2404947A1 (de) | Neue steroidverbindungen, verfahren zu ihrer herstellung und deren verwendung | |
| DE1468886B1 (de) | Verfahren zur Herstellung von Steroid-3,5-dien-1,3-diaminen bzw. von Steroid-1,3,5-trien-3-aminen | |
| DE1568222A1 (de) | Verfahren zur Herstellung von Diaethern des Helveticosids und Helveticosols | |
| DE3026602A1 (de) | 14-oxo-15-halogen-e-homoeburnanderivate, verfahren zur herstellung derselben und von 14-oxo-15-hydroxyimino-e-homoeburnanderivaten und die ersteren enthaltende arzneimittel | |
| DE1904586C3 (enExample) | ||
| DE1620745A1 (de) | Verfahren zur Herstellung von substituierten Chinolizinen | |
| DE1593315B1 (de) | 9-Isopropyliden-9,10-dihydroanthracen-10-carbonsaeure-ss-diaethylamino-aethylester,deren Salze und Verfahren zu deren Herstellung | |
| AT224274B (de) | Verfahren zur Herstellung von tert. Alkylaminsalzen von Steroidphosphatestern | |
| DE944247C (de) | Verfahren zur Herstellung von in 4- und 17(20)-Stellung ungesaettigten 3-Keto-21-Steroidcarbonsaeureestern | |
| DE1618028A1 (de) | Verfahren zur Herstellung von Methylacyloxymethylketalen aus Prednisolonderivaten mit 3 bis 5 C-Atomen in der Acylgruppe | |
| DE1902651C3 (de) | Neue Kortikoid-21-monophosphate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| AT249865B (de) | Verfahren zur Herstellung neuer Pyrazolverbindungen der Pregnanreihe | |
| AT216151B (de) | Verfahren zur Herstellung von Deserpidinsäureestern | |
| DE893790C (de) | Verfahren zur Herstellung von A9,11-12-Ketocyclopentanopoly-hydrophenanthrenen | |
| DE949056C (de) | Verfahren zur Herstellung von 4-Halogen-21-acyloxy-17-oxypregnan-3, 11, 20-trionen | |
| DE883604C (de) | Verfahren zur Herstellung von gesaettigten und ungesaettigten Derivaten von Pregnan-dion-3, 20, welche in 21-Stellung substituiert sind | |
| DE653934C (de) | Verfahren zur Darstellung von Kohlensaeureestern von Sexualhormonen | |
| AT266833B (de) | Verfahren zur Herstellung von neuen 1-[4-Oxo-4-(4-fluor-phenyl)-butyl]-piperidinen sowie von deren Säureadditionssalzen | |
| DE1267219B (de) | Verfahren zur Abtrennung von 17alpha-AEthinyl-19-nor-delta 4-androsten-17beta-ol-3-on | |
| DE945507C (de) | Verfahren zur Herstellung von 4-Halogenpregnan-17ª‡, 21-diol-3, 11, 20-trion-21-acylatn |